Weiya Pei
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Immunology 11
- Immunotherapy and Immune Responses 6
- Immune Cell Function and Interaction 6
- T-cell and B-cell Immunology 5
- IL-33, ST2, and ILC Pathways 4
-
- Extracellular vesicles in disease 5
- RNA modifications and cancer 2
- Co-authors
- Kun Lv (7 shared papers)Xueqin Li (6 shared papers)Xiaolong Zhu (6 shared papers)Min Zhong (3 shared papers)Xin Wan (7 shared papers)Khawar Ali Shahzad (7 shared papers)Chuanlai Shen (7 shared papers)Mengying Zhang (4 shared papers)
- Journals
- Immunological Investigations (2 papers)International Immunopharmacology (2 papers)BMC Pulmonary Medicine (1 paper)ACS Nano (1 paper)Cancer Immunology Immunotherapy (1 paper)
- Partner nations
- ChinaBangladeshPakistan
In The Last Decade
Weiya Pei
17 papers receiving 455 citations
Weiya Pei's Hit Papers
Peers
Comparison fields: 5 of 82
- Immunology 179
- Cancer Research 89
- Pharmaceutical Science 23
- Molecular Biology 231
- Biomaterials 38
Countries citing papers authored by Weiya Pei
This map shows the geographic impact of Weiya Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiya Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiya Pei more than expected).
Fields of papers citing papers by Weiya Pei
This network shows the impact of papers produced by Weiya Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiya Pei. The network helps show where Weiya Pei may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiya Pei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 78 | |
| 2 | 2023 | 67 | |
| 3 | Multitargeted Immunomodulatory Therapy for Viral Myocarditis by Engineered Extracellular Vesicles Hit paper breakdown → | 2024 | 52 |
| 4 | 2018 | 37 | |
| 5 | 2020 | 34 | |
| 6 | 2020 | 32 | |
| 7 | 2017 | 24 | |
| 8 | 2022 | 24 | |
| 9 | 2018 | 24 | |
| 10 | 2020 | 20 | |
| 11 | 2019 | 16 | |
| 12 | 2018 | 14 | |
| 13 | 2019 | 13 | |
| 14 | 2023 | 8 | |
| 15 | 2017 | 6 | |
| 16 | 2023 | 4 | |
| 17 | 2025 | 2 |
About Weiya Pei
Weiya Pei is a scholar working on Immunology, Molecular Biology, Cancer Research, Surgery and Cardiology and Cardiovascular Medicine, having authored 17 papers that have together received 455 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (6 papers), Extracellular vesicles in disease (5 papers), T-cell and B-cell Immunology (5 papers), IL-33, ST2, and ILC Pathways (4 papers), Cancer-related molecular mechanisms research (3 papers), RNA modifications and cancer (2 papers) and Eosinophilic Esophagitis (2 papers). The work is most often cited by research in Immunology (179 citations), Cancer Research (89 citations), Pharmaceutical Science (23 citations), Molecular Biology (231 citations) and Biomaterials (38 citations). Weiya Pei has collaborated with scholars based in China, Bangladesh and Pakistan. Frequent co-authors include Kun Lv, Xueqin Li, Xiaolong Zhu, Min Zhong, Xin Wan, Khawar Ali Shahzad, Chuanlai Shen, Mengying Zhang, Hui Yang and Yingying Zhang. Their work appears in journals such as Immunological Investigations, International Immunopharmacology, BMC Pulmonary Medicine, ACS Nano and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.